pubmed-article:10754294 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:10754294 | lifeskim:mentions | umls-concept:C0027651 | lld:lifeskim |
pubmed-article:10754294 | lifeskim:mentions | umls-concept:C0330390 | lld:lifeskim |
pubmed-article:10754294 | lifeskim:mentions | umls-concept:C0022688 | lld:lifeskim |
pubmed-article:10754294 | lifeskim:mentions | umls-concept:C0282552 | lld:lifeskim |
pubmed-article:10754294 | lifeskim:mentions | umls-concept:C0538072 | lld:lifeskim |
pubmed-article:10754294 | lifeskim:mentions | umls-concept:C0539791 | lld:lifeskim |
pubmed-article:10754294 | lifeskim:mentions | umls-concept:C1512505 | lld:lifeskim |
pubmed-article:10754294 | lifeskim:mentions | umls-concept:C0035015 | lld:lifeskim |
pubmed-article:10754294 | lifeskim:mentions | umls-concept:C1332682 | lld:lifeskim |
pubmed-article:10754294 | lifeskim:mentions | umls-concept:C1332686 | lld:lifeskim |
pubmed-article:10754294 | lifeskim:mentions | umls-concept:C1704869 | lld:lifeskim |
pubmed-article:10754294 | lifeskim:mentions | umls-concept:C1882923 | lld:lifeskim |
pubmed-article:10754294 | lifeskim:mentions | umls-concept:C1548437 | lld:lifeskim |
pubmed-article:10754294 | lifeskim:mentions | umls-concept:C0086597 | lld:lifeskim |
pubmed-article:10754294 | lifeskim:mentions | umls-concept:C0591833 | lld:lifeskim |
pubmed-article:10754294 | pubmed:issue | 8 | lld:pubmed |
pubmed-article:10754294 | pubmed:dateCreated | 2000-5-9 | lld:pubmed |
pubmed-article:10754294 | pubmed:abstractText | CK beta-11 chemoattracts T cells, B cells, dendritic cells, macrophage progenitors, and NK cells and facilitates dendritic cell and T cell interactions in secondary lymphoid tissues. We hypothesized that expression of CK beta-11 in tumor cells may generate antitumor immunity through these interactions. After transduction with the retroviral vector L(CK beta 11)SN, the murine breast cancer cell line C3L5 (C3L5-CK beta 11) showed expression of retroviral mRNA by Northern analysis and production of functional CK beta-11 by chemotaxis of human NK cells to C3L5-CK beta 11 supernatant. Only 10% of mice injected with C3L5-CK beta 11 developed tumors, compared with 100% of mice injected with a transduced control C3L5 line (C3L5-G1N). Importantly, the in vitro growth characteristics of the CK beta-11-transduced cell line were unaffected, suggesting the difference in growth in vivo was a result of chemokine production. Vaccination with C3L5-CK beta 11 partially protected animals from parental C3L5 challenge. Immunodepletion with anti-asialo-GM1 or anti-CD4 during C3L5-CK beta 11 vaccination significantly reduced CK beta-11 antitumor activity compared with control and anti-CD8-treated groups. Splenocytes from NK-depleted animals transferred the acquired immunity generated with C3L5-CK beta 11 vaccination, while splenocytes from the CD4-depleted animals did not. These results indicate, for the first time, that expression of CK beta-11 in a breast cancer cell line mediates rejection of the transduced tumor through a mechanism involving NK and CD4+ cells. Furthermore, CK beta-11-transduced tumor cells generate long-term antitumor immunity that requires CD4+ cells. These studies demonstrate the potential role of CK beta-11 as an adjuvant in stimulating antitumor responses. | lld:pubmed |
pubmed-article:10754294 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10754294 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10754294 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10754294 | pubmed:language | eng | lld:pubmed |
pubmed-article:10754294 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10754294 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:10754294 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10754294 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10754294 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10754294 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10754294 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10754294 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:10754294 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:10754294 | pubmed:month | Apr | lld:pubmed |
pubmed-article:10754294 | pubmed:issn | 0022-1767 | lld:pubmed |
pubmed-article:10754294 | pubmed:author | pubmed-author:KaplanM HMH | lld:pubmed |
pubmed-article:10754294 | pubmed:author | pubmed-author:BroxmeyerH... | lld:pubmed |
pubmed-article:10754294 | pubmed:author | pubmed-author:KimC HCH | lld:pubmed |
pubmed-article:10754294 | pubmed:author | pubmed-author:FORTD JDJ | lld:pubmed |
pubmed-article:10754294 | pubmed:author | pubmed-author:CornettaKK | lld:pubmed |
pubmed-article:10754294 | pubmed:author | pubmed-author:BreenG EGE | lld:pubmed |
pubmed-article:10754294 | pubmed:author | pubmed-author:FosterR GRG | lld:pubmed |
pubmed-article:10754294 | pubmed:author | pubmed-author:HromasRR | lld:pubmed |
pubmed-article:10754294 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:10754294 | pubmed:day | 15 | lld:pubmed |
pubmed-article:10754294 | pubmed:volume | 164 | lld:pubmed |
pubmed-article:10754294 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:10754294 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:10754294 | pubmed:pagination | 4025-31 | lld:pubmed |
pubmed-article:10754294 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:10754294 | pubmed:meshHeading | pubmed-meshheading:10754294... | lld:pubmed |
pubmed-article:10754294 | pubmed:meshHeading | pubmed-meshheading:10754294... | lld:pubmed |
pubmed-article:10754294 | pubmed:meshHeading | pubmed-meshheading:10754294... | lld:pubmed |
pubmed-article:10754294 | pubmed:meshHeading | pubmed-meshheading:10754294... | lld:pubmed |
pubmed-article:10754294 | pubmed:meshHeading | pubmed-meshheading:10754294... | lld:pubmed |
pubmed-article:10754294 | pubmed:meshHeading | pubmed-meshheading:10754294... | lld:pubmed |
pubmed-article:10754294 | pubmed:meshHeading | pubmed-meshheading:10754294... | lld:pubmed |
pubmed-article:10754294 | pubmed:meshHeading | pubmed-meshheading:10754294... | lld:pubmed |
pubmed-article:10754294 | pubmed:meshHeading | pubmed-meshheading:10754294... | lld:pubmed |
pubmed-article:10754294 | pubmed:meshHeading | pubmed-meshheading:10754294... | lld:pubmed |
pubmed-article:10754294 | pubmed:meshHeading | pubmed-meshheading:10754294... | lld:pubmed |
pubmed-article:10754294 | pubmed:meshHeading | pubmed-meshheading:10754294... | lld:pubmed |
pubmed-article:10754294 | pubmed:meshHeading | pubmed-meshheading:10754294... | lld:pubmed |
pubmed-article:10754294 | pubmed:meshHeading | pubmed-meshheading:10754294... | lld:pubmed |
pubmed-article:10754294 | pubmed:meshHeading | pubmed-meshheading:10754294... | lld:pubmed |
pubmed-article:10754294 | pubmed:meshHeading | pubmed-meshheading:10754294... | lld:pubmed |
pubmed-article:10754294 | pubmed:meshHeading | pubmed-meshheading:10754294... | lld:pubmed |
pubmed-article:10754294 | pubmed:meshHeading | pubmed-meshheading:10754294... | lld:pubmed |
pubmed-article:10754294 | pubmed:meshHeading | pubmed-meshheading:10754294... | lld:pubmed |
pubmed-article:10754294 | pubmed:meshHeading | pubmed-meshheading:10754294... | lld:pubmed |
pubmed-article:10754294 | pubmed:meshHeading | pubmed-meshheading:10754294... | lld:pubmed |
pubmed-article:10754294 | pubmed:meshHeading | pubmed-meshheading:10754294... | lld:pubmed |
pubmed-article:10754294 | pubmed:year | 2000 | lld:pubmed |
pubmed-article:10754294 | pubmed:articleTitle | The CC chemokine CK beta-11/MIP-3 beta/ELC/Exodus 3 mediates tumor rejection of murine breast cancer cells through NK cells. | lld:pubmed |
pubmed-article:10754294 | pubmed:affiliation | Departments ofMicrobiology/Immunology and Medicine (Hematology/Oncology), and Walther Oncology Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA. stephen_braun@hms.harvard.edu | lld:pubmed |
pubmed-article:10754294 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:10754294 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:10754294 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10754294 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10754294 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10754294 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10754294 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10754294 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:10754294 | lld:pubmed |